Krebs Biochem Standalone March 2021 Net Sales at Rs 15.86 crore, up 7.5% Y-o-Y
May 28, 2021 / 09:53 AM IST
Reported Standalone quarterly numbers for Krebs Biochemicals & Industries are:Net Sales at Rs 15.86 crore in March 2021 up 7.5% from Rs. 14.75 crore in March 2020.
Quarterly Net Loss at Rs. 6.99 crore in March 2021 down 13.47% from Rs. 6.16 crore in March 2020.
EBITDA stands negative at Rs. 4.08 crore in March 2021 down 3.55% from Rs. 3.94 crore in March 2020.
Krebs Biochem shares closed at 124.95 on May 27, 2021 (NSE) and has given 32.36% returns over the last 6 months and 53.69% over the last 12 months.
| Krebs Biochemicals & Industries | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'21 | Dec'20 | Mar'20 | | Net Sales/Income from operations | 15.86 | 6.46 | 10.22 | | Other Operating Income | -- | -- | 4.54 | | Total Income From Operations | 15.86 | 6.46 | 14.75 | | EXPENDITURE | | Consumption of Raw Materials | 6.04 | 2.55 | 8.11 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 2.91 | 2.25 | -2.06 | | Power & Fuel | -- | -- | -- | | Employees Cost | 4.02 | 3.87 | 4.05 | | Depreciation | 1.41 | 1.24 | 1.23 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 7.42 | 6.55 | 8.68 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -5.94 | -10.00 | -5.27 | | Other Income | 0.44 | 3.17 | 0.10 | | P/L Before Int., Excpt. Items & Tax | -5.49 | -6.83 | -5.17 | | Interest | 1.49 | 1.43 | 0.99 | | P/L Before Exceptional Items & Tax | -6.99 | -8.26 | -6.16 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -6.99 | -8.26 | -6.16 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -6.99 | -8.26 | -6.16 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -6.99 | -8.26 | -6.16 | | Equity Share Capital | 19.62 | 19.62 | 18.00 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -3.47 | -4.21 | -3.53 | | Diluted EPS | -3.47 | -4.21 | -3.78 | | EPS After Extra Ordinary | | Basic EPS | -3.47 | -4.21 | -3.53 | | Diluted EPS | -3.47 | -4.21 | -3.78 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Checkout Budget Highlights 2023
